5Libby P,Ridker PM,Maseri A.Inflammation and atherosclerosis.Circulation,2002,105:1135-1143.
6Chae CU,Lee RT,Rifai N,et al.Blood pressure and inflammation in apparently healthymen.Hypertension,2001,38:399-403.
7Anan F,Shimomura T,Kaku T,et al.High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis.Metabolism,2008,57:66-70.
8Wallenfeldt K,Hulthe J,Bokemark L,et al.Carotid and femoral atherosclerosis,cardiovascular risk factors and C-reactive protein inrelation to smokeless tobacco use or smoking in 58-year-old men.J Intern Med,2001,250:492-501.
9Trujillo ME,Scherer PE.Adiponectin-jorney from an adipocyte secretory protein to biomarker of the metabolic syndrome.J Intern Med,2005,257:167-175.
10Verma S,Wang CH,Li SH,et al.A self-fulfilling prophecy:C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.Circulation,2002,106:913-919.
7Crino JG. Dementia after stroke:High incideme and intriguing associations strokes J. Stroke ,2002,33:2261-2262.
8Katzman R, Hill LR, Yu ES, et al. The malignancy ofdementia. Predictors of mortality in clinicallydiagnoseddementia in a population survey of Shanghai, China. Arch Neurol, 1994,51 : 1220- 1225.
9[3]Millikan CH,Siekert RC.Studies in cerebrovasculau disease,I:syndrome of intermittent insufficiency of the Carotid arterial system[J].Proc Staff Meet Mayo Clin,1955,30(9):61-68.
